Efficacy and safety of a preventive strategy against tuberculosis in liver transplantation recipients including the treatment of latent infection with moxifloxacin
A preventive strategy based on systematic LTBI screening and moxifloxacin treatment before LT in positive cases appears safe and effective in preventing the development of tuberculosis in LT recipients. However, our findings are limited by a small sample size; thus, larger studies are required to validate our observations.
Authors
- Mario Fernández‐Ruiz (ORCID: https://orcid.org/0000-0002-0315-8001)
- Carlos Lumbreras (ORCID: https://orcid.org/0000-0003-4748-8288)
- Isabel Rodríguez‐Góncer (ORCID: https://orcid.org/0000-0003-2150-5748)
- Tamara Ruiz‐Merlo (ORCID: https://orcid.org/0000-0002-8261-6057)
- José María Caso (ORCID: https://orcid.org/0000-0001-5087-0299)
- Francisco López‐Medrano (ORCID: https://orcid.org/0000-0001-5333-7529)
- Carmelo Loinaz (ORCID: https://orcid.org/0000-0002-1873-0568)
- Alessandro Visentin (ORCID: https://orcid.org/0000-0001-5097-8750)
- José Tiago Silva (ORCID: https://orcid.org/0000-0001-8765-3466)
- Jesús González‐Olmedo
- José María Aguado (ORCID: https://orcid.org/0000-0002-9520-8255)
- Marina Fayos (ORCID: https://orcid.org/0000-0002-6371-6036)
- Rafael San Juan (ORCID: https://orcid.org/0000-0003-3446-1991)
- Alejandro Manrique (ORCID: https://orcid.org/0000-0003-4758-9927)
Institutions
- University of Verona (IT)
- Universidad Complutense de Madrid (ES)
- Instituto de Salud Carlos III (ES)
- Research Institute Hospital 12 de Octubre (ES)
- Centro de Investigación Biomédica en Red (ES)
Publication Details
- Journal
- Transplant Infectious Disease
- Published
- 2024-09-28
- DOI
- https://doi.org/10.1111/tid.14382
- Citations
- 3
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 1.17
Funders
- Instituto de Salud Carlos III